The following data is from the
 National Toxicology Program


06/29/94

MATERIAL SAFETY DATA SHEET

Section I: Chemical Identification

Product #: 24002-8 Name: 2,6-DI-Tert-Butyl-4-Methylphenol, 99+%

Section II: Composition/Information On Ingredients

CAS#: 128-37-0 MF: C15H24O Synonyms: Advastab 401 * Agidol * Agidol * Alkofen BP * AnTIOXIDANT DBPC * ANTIOXIDANT 4 * ANTIOXIDANT 29* ANTIOXIDANT 30* ANTIOX-IDANT 4K* ANTIOXIDANT KB * ANTRANCINE 8 * AO 29 * AO 4K * BHT * BHT (FOOD GRADE)* 2,6-BIS(1,1-DIMETHYLETHYL)-4-METHYLPHENOL * BUKS * BUTYLATED HYDROXYTOLUENE *BUTYLHYDROXYTOLUENE *BUTYLOHYDROKSYTOLUENU (POLISH) * CAO 1 * CAO 3* CATALIN CAO-3* CHEMANOX 11 * DALPAC * DBMP * DBPC * HYDROXYTOLUENE * 2,6-DI-TERT-BUTYL- P-METHYLPHENOL * 2,6-DI-TERT-BUTYL-4-METHYL PHENOL * 4-HYDROXY-3,5-DI-TERT-BUTYL -4-HYDROXYTOLUENE * 2,6-DI-TERT-BUTYL-P-METHYLPHENOL * 2,6-DI-TERT-BUTYL-4-METH-OL PHENOL * 4-HYDROXY-3,5-DI-TERT-BUTYLTOLUENE * IMPRUVOL * IDNOL * IDNOL 1 * IONOL (ANTIOXIDANT) * IONOL CP * IDNOLE * KERABIT * 4-METHYL-2,6-DI-TERC.BUTYL-PHENOL * NCI-C03598 * NOCRAC 200 * NONOX TBC * P 21* PARABAR 441 * PARANOX 441* PHENOL, 2,6-BIS(1,1-DIMETHYLETHYL)-4-METHYL-(9CI) * STAVOX * SUMILIZER BHT *SUSTANE * SUSTANE BHT * SWANOX BHT * TENAMENE 3* TENOX BHT * TOPANOL * TOPANOL D* TOPANOL DC* TOXOLAN P* VANLUBE PC* VANLUBE PCX * VIANOL * VULKANOX KB *

Section III: Hazards Identification

Label precautionary statements. Harmful. Harmful by inhalation,in contact with skin and if swallowed. Irritating to eyes, respiratory system and skin. Possible risk of irreversible effects. Possible carcinogen/mutagen. Target Organ(s): Lungs. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Do not breathe dust. Keep container tightly closed.
Wear suitable gloves and eye/face protection.

Section IV: First Aid Measures

In case of contact, immediately flush eyes or skin with copious amounts of water for at least 15 minutes while removing contaminated clothing and shoes. Assure adequate flushing of the eyes by separating the eyelids with fingers. If inhaled, remove to fresh air. If not breathing give artificial respiration. If breathing is difficult, give oxygen. If swallowed, wash out mouth with water
provided person is conscious. Call a physician. Wash contaminated clothing
before reuse.

Section V: Fire Fighting Measures

Extinguishing media. Carbon Dioxide dry chemical powder or appropriate foam. Special firefighting procedures: Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes. Unusual fire and explosions hazards. Emits toxic fumes under fire conditions.

Section VI: Accidental Release Measures

Evacuate area. Wear self-contained breathing apparatus, rubber boots and heavy rubber gloves. Cover with dry lime or soda ash, pickup, keep in a closed container and hold for waste disposal. Ventilate area and wash spill site after material pick up is complete.

Section VII: Handling And Storage

Refer to sectin 8

Section VIII: Exposure Controls/Personal Protection

Wear appropriate NIOSH/MSHA approved respirator, chemical resistant gloves, safety goggles, other protective clothing. Safety shower and eye bath. Use only in a chemical fume hood. Do not breathe dust. Do not get in eyes, on skin, on clothing. Avoid prolonged or repeated exposure. Wash thoroughly after handling. Possible carcinogen/mutagen. Harmful solid. Irritant. Keep tightly closed. Store in a cool dry place.

Section VIIII: Physical And Chemical Properties

Appearance and odor: White crystals. Boiling Point: 265 C Melting Point: 69 C to 70 C. Autoignition Tempearature: 878 F 469 C; Vapor Pressure: 0.01MM 20 C Vapor Density: 7.6

Section X: Stability And Reactivity

Incompatibilities; acid chlorides; acid anhydrides; oxidizing agents; bases; corrodes steel; brass; copper alloys. Hazardous combustion or decomposition products. Toxic fumes of: Carbon Monoxide, Carbon Dioxide.

Section XI: Toxicological Information

Acute Effects:

Harmful if swallowed, inhaled or absorbed through skin. Causes eye and skin irritation. Material is irritating to mucous membranes and upper respiratory tract. Depending on the intensity and duration of exposure, effects may vary from mild irritation to severe destruction of tissue. Prolonged contact can cause: damage to the eyes, nausea dizziness and headache.

Chronic Effects:

Possible carcinogen. Laboratory experiments have shown mutagenic efffects. Target Organ(s): lungs. RTECS NO: G07875000 P-cresol, 2,6-Di-tert-butyl-

Irritation Data:

SKN-HMN 500 MG/48 H MLD AMIHBC 5,311,52
SKN-RBT 500 MG/48H MOD AMIHBC 5,311,52
EYE-RBT 100 MG/24H MOD 85JCAE-,229,86

Toxicity Data:

ORL-RAT LD50: 890 MG/KG NEOLA4 24,253,77
ORL-MUS LD50: 650 MG/KG SRTCAC 36(1-4),10,89
IPR-MUS LD50: 138 MG/KG TXAPA9 61,475,81
IVN-MUS LD50: 180 MG/KG JMCMAR 23,1350,80
ORL-GPG LD50: 10700 MG/KG AMIHAB 11,93,55

Target Organ Data:

Behavioral (sleep)
Behavioral (tremor)
Behavioral (coma)
Lungs, thorax or respiration (chronic pulmonary edema or congestion)
Lungs, thorax or respiration (respiratory depression).
Lungs, thorax or respiration (other changes)
Lungs, thorax or respiration (tumors)
Gastrointestinal (gastritis)
Gastrointestinal (hypermotility, diarrhea)
Gastrointestinal (tumors)
Liver (tumors)
Blood (hemorrhage)
Specific developmental abnormalities (musculoskeletal system)
Tumorigenic (carcinogenic by RTECS criteria)
Tumorigenic (neoplastic by RTECS criteria)

Only selected registry of toxic effects of chemical substances (RTECS) data is presented here. See actual entry in RTECS for complete information.

Section XII: Ecological Information

Data not yet available

Section XIII: Disposal Considerations

Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Observe all Federal, State and Local environmental regulations.

Sectin XIIII: Transport Information

Contact Aldrich Chemical Company for transportation information

Section XV: Regulatory Information

Reviews, standards, and regulations.

ACGIH TLV-TWA 10 MG/M3 85INAB 6,536,91
IARC CANCER REVIEW: ANIMAL LIMITED EVIDENCE IMEMDT 40,161,86
IARC CANCER REVIEW: HUMAN NO ADEQUATE DATA IMEMDT 40,161,86
IARC CANCER REVIEW: GROUP 3 IMSUDL 7,56,87
OSHA PEL FINAL: 8H TWA 10 MG/M3
FEREAC 54,2923,89
DEL-AUSTRALIA: TWA 10 MG/M3 JAN93
DEL-BELGIUM: TWA 10 MG/M3 JAN93
DEL-FINLAND: TWA 10 MG/M3; STEL 20 MG/M3; SKIN JAN93
DEL-FRANCE: TWA 10 MG/M3 JAN93
DEL-THE NETHERLANDS: TWA 10 MG/M3 JAN93
DEL-SWITZERLAND: TWA 10 MG/M3 JAN93
DEL-UNITED KINGDOM: TWA 10 MG/M3 JAN93
DEL-IN BULGARIA, COLUMBIA, JORDAN, KOREA, CHECK ACGIH TLV
DEL IN NEW ZEALAND, SINGAPORE, VIETNAM CHECK ACGIH TLV
NIOSH REL TO 2,6-DI-T-BUTYL-P-CRESOL-AIR: 10H TWA 10 MG/M3
NIOSH * DHHS #92-100,92
NOHS 1974: HZD 83383; NIS 32; TNF 1526; NOS 39; TNE 28860
NOES 1983: HZD 83383; NIS 197; TNF 23433; NOS 149; TNE 467180; IFE 13294
EPA GENETOX PROGRAM 1988, POSITIVE: D MELANOGASTER-WHOLE SEX CHROMLOSS
EPA GENETOX PROGRAM 1988, NEGATIVE: HISTIDINE REVERSION-AMES TEST: MOUSE
SPECIFIC LOCUS
EPA GENETOX PROGRAM 1988, NEGATIVE: HISTIDINE REVERSION-AMES TEST; MOUSE SPECI-
FIC LOCUS.
EPA GENETOX PROGRAM 1988, NEGATIVE: D MELANOGASTER SEX-LINKED LETHAL
EPA GENETOX PROGRAM 1988, INCONCLUSIVE: D MELANOGASTER-RECIPROCAL TRANSLOCATION
EPA GENETOX PROGRAM 1988, INCONCLUSIVE: MAMALIAN MICRONUCLEUS; SPERM MORPHOLOGY
MOUSE.
EPA TSCA CHEMICAL INVENTORY, JUNE 1993
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 1994
NCI CARCINOGENESIS BIOASSAY (FEED) NO EVIDENCE: MOUSE, RAT
NCITR* NCI-TR-150,79


This Website was created for Distributor # M192

Copyright © 1997-2001 by Christina and Donovan Bray. All rights reserved.